proton pump inhibitor

Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

proton pump inhibitor

Any of a class of drugs that inhibit gastric acid secretion by interfering with the movement of hydrogen ions across cell membranes and are used mainly to treat peptic ulcers and gastroesophageal reflux disease.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Mentioned in ?

References in periodicals archive ?

Proton pump inhibitor prescribing patterns in the UK: a primary care database study.

Use of a proton pump inhibitor: Not more not less

How should Helicobacter pylori eradication be done in the extensive proton pump inhibitor allergy?

Re: How Should Helicobacter Pylori Eradication Be Performed in Cases of Extensive Allergies to Proton Pump Inhibitors?

For decades, people have been taking proton pump inhibitor drugs (PPIs) like Prilosec OTC[R] and Nexium[R] to treat heartburn, acid reflux, ulcers, and other related ailments.

Proton Pump Inhibitors Raise Risk of Liver Cancer

Hypomagnesemia among outpatient long-term proton pump inhibitor users.

Q / How often does long-term PPI therapy cause clinically significant hypomagnesemia?

"Our findings do not support previous assumptions that long-term proton pump inhibitor use would be associated with an increased risk of hip fractures," the authors write.

Short-Term PPIs Tied to Higher Hip Fracture Risk in Alzheimer's; No association seen with long-term or cumulative proton pump inhibitor use in Alzheimer's patients

The patient was evaluated by a neurosurgeon who recommended 6-8 weeks of cervical collar and treatment with dexamethasone along with proton pump inhibitor (PPI) for ulcer prophylaxis.

Pantoprazole-Induced Delirium: Review of a Case and Associated Literature

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med 2010;170:704-10.

Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Propensity Score Analysis

announced today that Eisai has obtained the approval of additional dosage and administration in Japan of the proton pump inhibitor Pariet 5 mg Tablets and 10 mg Tablets (generic name: rabeprazole sodium) to administer 10 mg of rabeprazole sodium per dose twice-daily for the maintenance therapy of proton pump inhibitor-resistant reflux esophagitis (reflux esophagitis in which it is difficult to achieve satisfactory therapeutic effects by existing treatment with once-daily dosing of proton pump inhibitors).

Eisa: Additional Dosage and Administration of Proton Pump Inhibitor Pariet 5 mg Tablets, 10 mg Tablets Approved in Japan for Maintenance Therapy of Proton Pump Inhibitor Resistant Reflux Esophagitis

Ref: "Association Between Proton Pump Inhibitor Use and Risk o Progression of Chronic Kidney Disease", Derk C.F.

PPIs can increase risk of kidney disease

Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.

Using proton-pump inhibitors among hemodialysis patients - single academic dialysis center's preliminary experience

If you take a proton pump inhibitor (PPI) for heartburn or gastroesophageal reflux disease (GERD), you may be putting yourself at higher risk for an ischemic stroke, according to a study presented at the American Heart Association Scientific Sessions in November 2016.